Onkure Therapeutics Inc-a (OKUR) Institutional Holdings & 13F Data (Q2 2026)

OKUR ranks #5197 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

76 institutions disclose a position in OKUR, but none treat it as a major bet — even Acorn Capital Advisors, LLC, its most concentrated holder, allocates just 3.5% of its own portfolio to it.

StepStone Group LP has added to its OKUR position for two straight quarters, increasing it by $10.8M to reach $12.1M today.

Shay Capital LLC has trimmed its OKUR position for two straight quarters, cutting it by $2.0M while still holding $228.0K.

OKUR is down 0.6% today, but institutions show net buying of $42.2M this quarter — a divergence between today's price move and the underlying institutional flow.

OKUR reported a net loss of $59.5M in its latest fiscal year.

• Not yet profitable — net loss of $59.5M in the latest fiscal year
• Net income declined year over year, from -$52.7M to -$59.5M
• Operating cash flow was negative, using $51.8M in cash
• Current ratio of 10.28x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.11x equity — within a conventional range